GALLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 15.884
EU - Europa 2.601
AS - Asia 2.127
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Totale 20.626
Nazione #
US - Stati Uniti d'America 15.866
IT - Italia 1.127
CN - Cina 1.028
SG - Singapore 892
FI - Finlandia 359
SE - Svezia 312
FR - Francia 232
DE - Germania 223
VN - Vietnam 119
GB - Regno Unito 115
UA - Ucraina 110
IN - India 53
IE - Irlanda 43
HK - Hong Kong 30
RU - Federazione Russa 27
NL - Olanda 26
CA - Canada 11
CH - Svizzera 7
ES - Italia 7
EU - Europa 5
IR - Iran 4
MK - Macedonia 4
RO - Romania 4
AU - Australia 3
MX - Messico 3
PR - Porto Rico 3
BR - Brasile 2
NO - Norvegia 2
DK - Danimarca 1
HN - Honduras 1
JO - Giordania 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 20.626
Città #
Fairfield 2.435
Woodbridge 1.659
Chandler 1.263
Houston 1.156
Ann Arbor 1.113
Ashburn 1.063
Wilmington 883
Cambridge 866
Seattle 832
Singapore 723
Santa Clara 687
Jacksonville 518
Boardman 397
Princeton 391
Medford 206
Beijing 203
San Diego 203
Nanjing 182
Roxbury 160
Des Moines 132
Milan 124
Dong Ket 119
Helsinki 118
Padova 112
Norwalk 102
Shenyang 69
Guangzhou 66
Hebei 66
Rome 65
Nanchang 55
Jiaxing 44
Dublin 43
Tianjin 32
Jinan 30
London 30
Hong Kong 29
Changsha 26
New York 26
Kharkiv 24
Bologna 17
Los Angeles 17
Vicenza 15
Paris 14
Pune 14
Ogden 13
Cagliari 12
Hefei 12
Turin 12
Haikou 11
Bari 10
Falls Church 10
Pisa 10
Borås 9
Buffalo 9
Florence 9
Kunming 9
Ancona 8
Hangzhou 8
Redwood City 8
Shanghai 8
Catania 7
Dallas 7
Genoa 7
Kilburn 7
Monza 7
Ningbo 7
Parma 7
Grignasco 6
Zhengzhou 6
Chongqing 5
Fuzhou 5
Moscow 5
Pescara 5
Porto Torres 5
Redmond 5
Rockville 5
Taiyuan 5
Verona 5
Washington 5
Albignasego 4
Bolzano 4
Brescia 4
Chiaravalle 4
Chiswick 4
Copertino 4
Frankfurt am Main 4
Indiana 4
Martellago 4
Misterbianco 4
Napoli 4
Santa Croce sull'Arno 4
Sassari 4
Venice 4
Alessandria 3
Battaglia Terme 3
Brentonico 3
Caserta 3
Cernusco sul Naviglio 3
Collecorvino 3
Desio 3
Totale 16.675
Nome #
La Sintesi Intratecale di IgG nella Sclerosi Multipla: confronto fra Isoelectricfocusing, IgG index (indice di Link) e Intra-BBB IgG Syn Rate (formula di Tourtellotte). 443
Interleuchina 2 (IL-2) e recettore solubile dell’IL-2 (sIL-2R) nella Sclerosi Multipla. 397
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study 166
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 144
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset 139
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study 136
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: A common, transient and clinically silent phenomenon 133
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. 132
Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset 128
A new integrated dual time-point amyloid PET/MRI data analysis method 127
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy 127
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study 125
Cortical relapses in multiple sclerosis 125
Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination 122
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. 120
Acute disseminated encephalomyelitis in children: focus on relapsing patients. 119
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 119
Magnetic Resonance Evidence of Cerebellar Cortical Pathology in Multiple Sclerosis. 118
The incidence and significance of anti-natalizumab antibodies. Results from the AFFIRM and SENTINEL . 114
Immunological findings in the CSF of HIV-1-infected patients. 114
Investigation of the neural correlates underlying action observation in multiple sclerosis patients 113
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 112
Specific smell dysfunctions in relapsing-remitting multiple sclerosis 111
'Hidden' factors influencing quality of life in patients with multiple sclerosis 110
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. 108
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study 107
Free light chains in the CSF in multiple sclerosis. 107
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients 106
Neurofunctional modulation of brain regions by the observation of pointing and grasping actions 106
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis. 106
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. 105
The parallel analysis of phase sensitive inversion recovery (PSIR) and double inversion recovery (DIR) images significantly improves the detection of cortical lesions in multiple sclerosis (MS) since clinical onset 105
Cortical lesions and cognitive impairment in multiple sclerosis. 104
Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. 104
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset 104
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. 103
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. 103
A case of relapsing-remitting tumour-like inflammation of the central nervous system 103
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 102
No MRI evidence of cortical lesions in neuromyelitis optica 102
Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis 102
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. 101
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 101
Transferrin Receptors in the Central Nervous System. 100
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. 100
Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis 100
Central nervous system involvement in HIV infection. 100
Automatic segmentation of gray matter multiple Sclerosis lesions on DIR images 99
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 98
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. 97
Lipids in multiple sclerosis. 97
Cognitive and psychosocial features of childhood and juvenile MS. 96
Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study 95
CCSVI and MS: no meaning, no fact. 95
Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. 95
Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function. 94
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. 94
Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation. 93
Free Light-chains of Immunoglobulins In the Cerebrospinal-fluid of Human-immunodeficiency-virus Type-1-infected Patients 93
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis 92
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. 92
The range of multiple sclerosis associated with neurofibromatosis type 1 91
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis 91
The predictive value of gray matter atrophy in clinically isolated syndromes 91
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 91
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an italian cooperative study. 90
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis 90
Humoral immunity in multiple sclerosis cerebrospinal fluid: role of the blood-brain barrier integrity in the detection of intrathecally synthesized immunoglobulins. 90
Gray matter pathology in MS: A 3-year longitudinal study in a pediatric population 90
Sporadic Creutzfeldt-Jakob disease presenting with isolated progressive non-fluent aphasia in a young woman. 90
Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients. 89
Time-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients. 89
Prognostic indicators in pediatric clinically isolated syndrome 89
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 89
Cortical lesion load associates with progression of disability in multiple sclerosis. 88
Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands 88
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. 87
IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants. 87
PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East Italy 87
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 87
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 86
M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. 86
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 86
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. 85
Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy. 84
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset 84
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. 83
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification 83
Examinations of cerebrospinal fluid immunoglobulin G by chromatofocusing. 83
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis 83
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 82
A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis 81
Broad pH gradient chromatofocusing. 80
Increased incidence of multiple sclerosis in the Veneto region, Italy. 80
Action observation in early RRMS patient. A functional MRI study. 80
Genetic burden of common variants in progressive and bout-onset multiple sclerosis. 80
Immunological markers in the cerebrospinal fluid of HIV-1-infected children. 80
Early red nucleus atrophy in relapse-onset multiple sclerosis 80
A basic overview of multiple sclerosis immunopathology 80
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment 79
Totale 10.642
Categoria #
all - tutte 72.068
article - articoli 61.004
book - libri 148
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.188
Totale 141.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.126 0 0 0 0 0 0 367 433 466 441 214 205
2020/20212.339 103 193 70 144 140 158 64 208 283 332 275 369
2021/20223.159 159 351 281 175 173 301 119 321 195 97 275 712
2022/20232.648 547 227 65 297 417 372 23 177 351 19 115 38
2023/20241.401 59 206 181 117 91 112 64 99 49 54 177 192
2024/20252.623 49 598 336 327 1.151 159 3 0 0 0 0 0
Totale 20.777